Literature DB >> 23668504

The benefits and harms of breast cancer screening.

Alberto Donzelli.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23668504     DOI： 10.1016/S0140-6736(13)60619-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Impact of Detection Mode in a Large Cohort of Women Taking Part in a Breast Screening Program.

Authors:  Marilina García; Maximino Redondo; Irene Zarcos; Javier Louro; Francisco Rivas-Ruiz; Teresa Téllez; Diego Pérez; Francisco Medina Cano; Kenza Machan; Laia Domingo; Maria Del Mar Vernet; Maria Padilla-Ruiz; Xavier Castells; Maria Sala
Journal:  Eur J Breast Health       Date:  2022-04-01

2.  Values in breast cancer screening: an empirical study with Australian experts.

Authors:  Lisa Parker; Lucie Rychetnik; Stacy Carter
Journal:  BMJ Open       Date:  2015-05-20       Impact factor: 2.692

3.  Income inequality in uptake of voluntary versus organised breast cancer screening: evidence from the British Household Panel Survey.

Authors:  Patricia Carney; Ciaran O'Neill
Journal:  BMC Public Health       Date:  2018-02-14       Impact factor: 3.295

4.  Introducing a low-risk breast screening pathway into the NHS Breast Screening Programme: Views from healthcare professionals who are delivering risk-stratified screening.

Authors:  Victoria G Woof; Lorna McWilliams; Louise S Donnelly; Anthony Howell; D Gareth Evans; Anthony J Maxwell; David P French
Journal:  Womens Health (Lond)       Date:  2021 Jan-Dec

5.  The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary care.

Authors:  Sibel Saya; Lucy Boyd; Patty Chondros; Mairead McNamara; Michelle King; Shakira Milton; Richard De Abreu Lourenco; Malcolm Clark; George Fishman; Julie Marker; Cheri Ostroff; Richard Allman; Fiona M Walter; Daniel Buchanan; Ingrid Winship; Jennifer McIntosh; Finlay Macrae; Mark Jenkins; Jon Emery
Journal:  Trials       Date:  2022-09-27       Impact factor: 2.728
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.